MIRA INFORM REPORT

 

 

Report No. :

323681

Report Date :

25.05.2015

 

IDENTIFICATION DETAILS

 

Name :

ECLINICALWORKS INDIA PRIVATE LIMITED

 

 

Registered Office :

A-701 to 705 and Part of B1-706, Boomerang, Main Chandivali Farm Road, Near Chandivali Studio, Andheri (East), Mumbai – 400072, Maharashtra

Tel No.:

91- 22-67375000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

30.10.2006

 

 

Com. Reg. No.:

11-165289

 

 

Capital Investment / Paid-up Capital :

Rs.100.448 Million

 

 

CIN No.:

[Company Identification No.]

U72200MH2006PTC165289

 

 

TIN No.:

Not Available

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCE6639F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

To carry on the business of Information Technology (IT) services i.e. software development, software installation, software testing and other support services and IT enabled services

 

 

No. of Employees :

Information denied by management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “ECLINICALWORKS LCC U.S.A.” It is established company having satisfactory track record.

 

As per registrar of companies the date of balance sheet (i.e. financial field) is shown as 31.03.2014 but the documents related to the financials are not been available from any sources.

 

As per previous financial 2013, company has recorded healthy networth position backed by it zero debt balance sheet profile.

 

Rating takes into consideration company’s healthy financial and managerial support that company receives from its holding company.

 

Trade relations are fair. Business is active and payments are reported to be usually correct.

 

In a view of decent net worth base, managerial support from its holding company, the company can be considered for normal business dealings at usual trade terms and conditions.

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Vishal

Designation :

Accountant

Contact No.:

91-79-40222000

Date :

21.05.2015

 

 

LOCATIONS

 

Registered Office :

A-701 To 705 and Part of B1-706, Boomerang, Main Chandivali Farm Road, Near Chandivali Studio, Andheri (East), Mumbai – 400072, Maharashtra, India

Tel. No.:

91- 22-67375000

Fax No.:

Not Available

E-Mail :

sushil.jain@eclinicalworks.com

vishal.raval@eclinicworks.com

Website :

https://www.eclinicalworks.com

 

 

DIRECTORS

 

As on 30.06.2014

 

Name :

Mr. Mahesh Kumar Sunderdas Navani

Designation :

Director

Address :

33 Farmington Drive, Shrewsbury Ma, 01545, United States Of America

Date of Birth/Age :

09.02.1967

Date of Appointment :

18.12.2006

DIN No.:

00904484

 

 

Name :

Mr. Rajesh Bhagwandas Dharampuriya

Designation :

Director

Address :

37 Farmington Drive, Shrewsbury Ma, 01545, United States Of America

Date of Birth/Age :

05.10.1962

Date of Appointment :

03.04.1953

DIN No.:

00904503

 

 

Name :

Mr. Girish Motumal Navani

Designation :

Director

Address :

35, Farmington Drive, Shrewsbury Ma, 01545, United States Of America

Date of Birth/Age :

18.12.2006

Date of Appointment :

18.12.2006

DIN No.:

00907586

 

 

KEY EXECUTIVES

 

Name :

Mr. Vishal

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS

 

As on 30.06.2014

 

Names of Shareholders (Equity Shares)

 

No. of Shares

EClinicalWorks LLC, USA

 

6372904

EClinicalWorks LLC, USA Jointly with Girish Motumal Navani Jointly with Mahesh Kumar Sunderdas Navani Jointly with Rajesh Bhagwandas Dharampuriya

 

1

Total

 

6372905

 

 

Names of Shareholders (Preference Shares)

 

No. of Shares

EClinicalWorks LLC, USA

 

5200000

Total

 

5200000

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.06.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

To carry on the business of Information Technology (IT) services i.e. software development, software installation, software testing and other support services and IT enabled services

 

 

Products / Services :

Information Technology (IT) Services

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

 

Selling :

Not Divulged 

 

 

Purchasing :

Not Divulged 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

Not Divulged 

Contact No.:

Not Divulged 

Since How Long Known :

Not Divulged 

Experience :

Not Divulged 

Maximum Limit Dealt :

Not Divulged 

Remark :

Not Divulged 

 

 

Customers :

Reference :

Not Divulged 

Name of the Person :

Not Divulged 

Contact No.:

Not Divulged 

Since How Long Known :

Not Divulged 

Experience :

Not Divulged 

Maximum Limit Dealt :

Not Divulged 

Remark :

Not Divulged 

 

 

No. of Employees :

Information denied by management

 

 

Bankers :

Banker Name

Not Divulged 

Branch Address

Not Divulged 

Person Name (With Designation)

Not Divulged 

Contact Number

Not Divulged 

Name of Account Holder

Not Divulged 

Account Number

Not Divulged 

Account Since (Date/Year of Account Opening)

Not Divulged 

Average Balance Maintained (If Possible)

Not Divulged 

Credit Facilities Enjoyed (If any)

Not Divulged 

Account Operation

Not Divulged 

Remarks (If any)

Not Divulged 

 

Auditors :

 

Name :

Sameer B. Vageriya and Company

Chartered Accountants

Address :

504, Sheel Jeet Natwar Nagar, Road No. 5, Jogeswari (East), Mumbai - 400060 , Maharashtra, India

PAN No.:

AACPV4953B

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Holding Company :

EClinicalWorks LLC

 

 

CAPITAL STRUCTURE

 

As on 30.06.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9800000

Equity Shares

Rs.10/- each

Rs.98.000 Million

5200000

Preference Shares

Rs.10/- each

Rs.52.000 Million

 

Total

 

Rs.150.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6372905

Equity Shares

Rs.10/- each

Rs.63.729 Million

5200000

Preference Shares

Rs.10/- each

Rs.52.000 Million

 

Total

 

Rs.115.729 Million

 

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9800000

Equity Shares

Rs.10/- each

Rs.98.000 Million

5200000

Preference Shares

Rs.10/- each

Rs.52.000 Million

 

Total

 

Rs.150.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4844847

Equity Shares

Rs.10/- each

Rs.48.448 Million

5200000

Preference Shares

Rs.10/- each

Rs.52.000 Million

 

Total

 

Rs.100.448 Million

 

 


FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

100.448

96.191

73.560

(b) Reserves & Surplus

1,747.500

1,492.256

534.693

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

425.667

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2,273.615

1,588.447

608.253

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

(0.541)

3.489

0.434

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

(0.541)

3.489

0.434

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

11.784

14.837

8.805

(c) Other current liabilities

42.193

32.215

12.712

(d) Short-term provisions

82.232

45.055

24.378

Total Current Liabilities (4)

136.209

92.107

45.895

 

 

 

 

TOTAL

2,409.283

1,684.043

654.582

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

971.582

1,044.488

156.372

(ii) Intangible Assets

4.640

5.800

5.319

(iii) Capital work-in-progress

505.911

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

30.534

26.128

26.638

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1,512.667

1,076.416

188.329

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

309.986

161.544

79.708

(d) Cash and cash equivalents

483.693

394.272

345.238

(e) Short-term loans and advances

48.046

25.773

19.233

(f) Other current assets

54.891

26.038

22.074

Total Current Assets

896.616

607.627

466.253

 

 

 

 

TOTAL

2,409.283

1,684.043

654.582

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

 

 

INCOME

NA

NA

NA

 

 

 

 

 

 

EXPENSES

NA

NA

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

167.950

96.639

79.155

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

103.184

40.106

30.851

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

64.766

56.533

48.304

 

 

 

 

 

Less

TAX                                                                  (H)

22.348

15.455

8.687

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

42.418

41.078

39.617

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

123.227

82.209

42.652

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Preference Share Dividend

0.052

0.052

0.052

 

 

Dividend Distribution tax

0.008

0.008

0.008

 

BALANCE CARRIED TO THE B/S

165.585

123.227

82.209

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

ITES/ Software Service Fees raised during the year

784.097

511.498

349.355

 

TOTAL EARNINGS

784.097

511.498

349.355

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

3.67

NA

NA

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2013

31.03.2012

31.03.2011

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Return on Total Assets

(PBT/Total Assets}

(%)

3.40

3.36

7.38

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.03

0.04

0.08

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

6.58

6.60

10.16

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

73.560

96.191

100.448

Reserves & Surplus

534.693

1492.256

1747.500

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

425.667

Net worth

608.253

1588.447

2273.615

 

 

 

 

Long Term borrowings

0.000

0.000

0.000

Short Term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

----------

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter ID Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

No

21

Banking facility details

No

22

Conduct of the banking account

----------

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

No

27

Reasons for variation <> 20%

----------

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

----------

33

Market information

----------

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

BACKGROUND AND PRINCIPAL ACTIVITIES

 

The Company is incorporated on 30th October, 2006 as a private limited company. eClinicalWorks LLC (US) (the Group) (the holding company) of the Company. The holding company is a medical software company founded in 1999. It is a leader in the unified electronic medical record (EMR) and practice management (PM) market catering to a wide variety of practices in USA. The unit has been approved under the STP scheme of the Govt. of India as a 100 % export oriented unit for computer software. Company’s primary business is to carry on the business of Information Technology (IT) services i.e. software development, software installation, software testing and other support services and IT enabled services

 

 

OPERATIONS

 

The company has performed very well as compared to the previous year and expects to maintain the same level of growth and performance in future. The Company further plans to expand its operations in coming near future. We expect the growth to achieve new heights with such expansions.

 

The company specifically provides services to its parent Company, eClinicalWorks, LLC. eClinical US is a medical software company and it is a leader in the unified electronic medical record (EMR) and practice management (PM) market catering to a wide variety of practices in USA.

 

It is a product based proprietary software company. The company provides Information Technology and IT enabled services (e.g. trouble shooting, handling of client complaints etc.).

REVIEW OF PROGRESS

 

Prospects for the current financial year appear reasonable positive in view of the company's quality of work and adherence to schedules. eClinicalWorks India has been successful in creating the technical capabilities and expertise to perform the support services with respect to the eCW-USs business or the Products.

 

The Company endeavours to undertake expansion plans on a large scale in coming years in view of the encouraging performance and response from prospective clients. The Directors are hopeful of exploring newer market to reach maximum client base.

 

 

NO CHARGES EXIST FOR COMPANY 

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.57

UK Pound

1

Rs.99.67

Euro

1

Rs.70.83

 

 

INFORMATION DETAILS

 

Information Gathered by :

KSP

 

 

Analysis Done by :

MNJ

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.